Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Chemokine (C-C Motif) Ligand 2 (CCL2) Peptide

CCL2 Reactivity: Mammalian Host: Synthetic BP, IHC, WB
Catalog No. ABIN936932
  • Target See all CCL2 products
    CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
    Peptide Type
    Synthetic
    Origin
    Mammalian
    Source
    • 1
    Synthetic
    Application
    Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
    Sequence
    ASYRRITSSK CPKEAVIFKT IVAKEICADP KQKWVQDSMD HLDKQTQTPK
    Characteristics
    A synthetic peptide for use as a blocking control in assays to test for specificity of CCL2 antibody,
    Alternative Names: CCL2 control peptide, CCL2 antibody Blocking Peptide, Anti-CCL2 Blocking Peptide, chemokine, C-C motif ligand 2 Blocking Peptide, GDCF-2 Blocking Peptide, GDCF-2 HC11 Blocking Peptide, HC11 Blocking Peptide, HSMCR30 Blocking Peptide, MCAF Blocking Peptide, MCP-1 Blocking Peptide, MCP1 Blocking Peptide, MGC9434 Blocking Peptide, SCYA2 Blocking Peptide, SMC-CF Blocking Peptide, CCL2, CCL-2, CCL 2, CCL-2 Blocking Peptide, CCL 2 Blocking Peptide
  • Application Notes
    Optimal conditions should be determined by the investigator
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
    Buffer
    PBS
    Handling Advice
    Avoid repeated freeze/thaw cycles.
    Storage
    -20 °C
    Storage Comment
    Store at -20 °C long term.
  • Target
    CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
    Synonyms
    GDCF-2 Peptide, HC11 Peptide, HSMCR30 Peptide, MCAF Peptide, MCP-1 Peptide, MCP1 Peptide, SCYA2 Peptide, SMC-CF Peptide, AI323594 Peptide, JE Peptide, Scya2 Peptide, Sigje Peptide, MCP-1A Peptide, MCP1A Peptide, C-C motif chemokine ligand 2 Peptide, chemokine (C-C motif) ligand 2 Peptide, C-C motif chemokine 2 Peptide, CCL2 Peptide, Ccl2 Peptide, LOC101120093 Peptide
    Background
    CCL2 is a chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. CCL2 augments monocyte anti-tumor activity. CCL2 has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. CCL2 may be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis.
    Molecular Weight
    11 kDa
You are here:
Support